Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 08, 2022

SELL
$5.81 - $14.39 $7.41 Million - $18.4 Million
-1,275,876 Closed
0 $0
Q3 2021

Nov 09, 2021

SELL
$11.55 - $20.3 $9.84 Million - $17.3 Million
-851,759 Reduced 40.03%
1,275,876 $17.7 Million
Q2 2021

Aug 12, 2021

BUY
$17.9 - $23.29 $2.39 Million - $3.11 Million
133,689 Added 6.7%
2,127,635 $42.9 Million
Q1 2021

May 11, 2021

BUY
$13.71 - $30.64 $3.06 Million - $6.84 Million
223,352 Added 12.61%
1,993,946 $42.8 Million
Q4 2020

Feb 05, 2021

BUY
$9.31 - $14.0 $8.01 Million - $12 Million
860,167 Added 94.48%
1,770,594 $24.8 Million
Q3 2020

Nov 04, 2020

BUY
$9.1 - $15.81 $1.41 Million - $2.45 Million
155,060 Added 20.53%
910,427 $10.9 Million
Q2 2020

Aug 06, 2020

BUY
$11.29 - $16.0 $8.53 Million - $12.1 Million
755,367 New
755,367 $9.12 Million

Others Institutions Holding GTH

# of Institutions
1
Shares Held
7.5K
Call Options Held
0
Put Options Held
0

About Genetron Holdings Ltd


  • Ticker GTH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 90,602,304
  • Description
  • Genetron Holdings Limited, a precision oncology company, engages in the cancer molecular profiling, and harnessing technologies in molecular biology and data science for cancer treatment. The company offers diagnosis and monitoring services, and early screening services through laboratory developed tests services. It also provides in-vitro diagn...
More about GTH
Track This Portfolio

Track Jennison Associates LLC Portfolio

Follow Jennison Associates LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jennison Associates LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jennison Associates LLC with notifications on news.